Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Androgen | 14 | 2021 | 1087 | 1.520 |
Why?
|
SOX9 Transcription Factor | 4 | 2013 | 146 | 0.920 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2012 | 314 | 0.730 |
Why?
|
Prostate | 5 | 2021 | 1757 | 0.580 |
Why?
|
Prostatic Neoplasms | 13 | 2021 | 11092 | 0.550 |
Why?
|
High Mobility Group Proteins | 2 | 2008 | 179 | 0.540 |
Why?
|
Mammary Neoplasms, Animal | 2 | 2018 | 122 | 0.520 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2018 | 8601 | 0.460 |
Why?
|
Trans-Activators | 3 | 2013 | 2849 | 0.440 |
Why?
|
Down-Regulation | 5 | 2013 | 2924 | 0.380 |
Why?
|
Doxycycline | 1 | 2012 | 348 | 0.340 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 323 | 0.340 |
Why?
|
Androgens | 7 | 2018 | 1278 | 0.340 |
Why?
|
Transcription Factors | 6 | 2013 | 12122 | 0.300 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2012 | 2454 | 0.270 |
Why?
|
Cell Line, Tumor | 16 | 2021 | 17063 | 0.270 |
Why?
|
G1 Phase | 1 | 2006 | 403 | 0.240 |
Why?
|
Mammary Glands, Animal | 2 | 2018 | 272 | 0.230 |
Why?
|
Cell Proliferation | 4 | 2013 | 10428 | 0.200 |
Why?
|
Neoplasm Transplantation | 5 | 2018 | 2011 | 0.200 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2022 | 43 | 0.200 |
Why?
|
Cerebellar Cortex | 1 | 2022 | 108 | 0.190 |
Why?
|
p21-Activated Kinases | 3 | 2013 | 127 | 0.190 |
Why?
|
Ischemic Postconditioning | 1 | 2020 | 24 | 0.180 |
Why?
|
Neoplasm Proteins | 1 | 2013 | 3592 | 0.180 |
Why?
|
Mice, SCID | 4 | 2018 | 2627 | 0.170 |
Why?
|
beta Catenin | 4 | 2022 | 1044 | 0.160 |
Why?
|
Radioactive Pollutants | 1 | 2018 | 13 | 0.160 |
Why?
|
Chernobyl Nuclear Accident | 1 | 2018 | 15 | 0.160 |
Why?
|
Protein Phosphatase 1 | 2 | 2017 | 135 | 0.150 |
Why?
|
Positive Transcriptional Elongation Factor B | 1 | 2017 | 42 | 0.140 |
Why?
|
Wnt Proteins | 3 | 2013 | 722 | 0.140 |
Why?
|
Cell Growth Processes | 2 | 2008 | 380 | 0.130 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2021 | 750 | 0.130 |
Why?
|
Mice | 13 | 2022 | 81788 | 0.120 |
Why?
|
Phosphorylation | 5 | 2018 | 8278 | 0.120 |
Why?
|
Hospitals, Urban | 1 | 2017 | 493 | 0.120 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2018 | 540 | 0.120 |
Why?
|
Genes, Reporter | 1 | 2018 | 1524 | 0.110 |
Why?
|
Mice, Transgenic | 4 | 2018 | 9548 | 0.110 |
Why?
|
Mice, Inbred ICR | 2 | 2018 | 341 | 0.110 |
Why?
|
Myristic Acid | 1 | 2012 | 49 | 0.100 |
Why?
|
Transcription, Genetic | 3 | 2021 | 7599 | 0.100 |
Why?
|
Neoplasm Invasiveness | 2 | 2013 | 3597 | 0.100 |
Why?
|
Hospitals, Teaching | 1 | 2017 | 1157 | 0.100 |
Why?
|
Myeloproliferative Disorders | 1 | 2018 | 615 | 0.100 |
Why?
|
Dihydrotestosterone | 1 | 2013 | 193 | 0.100 |
Why?
|
Enzyme Induction | 1 | 2012 | 456 | 0.100 |
Why?
|
Breast Neoplasms | 4 | 2013 | 21064 | 0.100 |
Why?
|
CDC2 Protein Kinase | 2 | 2017 | 212 | 0.100 |
Why?
|
Neural Pathways | 1 | 2022 | 3087 | 0.090 |
Why?
|
Animals | 14 | 2022 | 168730 | 0.090 |
Why?
|
Protein Kinase C-alpha | 1 | 2011 | 112 | 0.090 |
Why?
|
Operon | 1 | 2012 | 371 | 0.090 |
Why?
|
Mammary Glands, Human | 1 | 2013 | 199 | 0.090 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2013 | 433 | 0.090 |
Why?
|
RNA, Small Interfering | 3 | 2016 | 3418 | 0.090 |
Why?
|
Epithelial Cells | 4 | 2018 | 3682 | 0.090 |
Why?
|
Fibrinolytic Agents | 1 | 2020 | 2082 | 0.090 |
Why?
|
Nerve Net | 1 | 2022 | 2310 | 0.090 |
Why?
|
Herpesvirus 4, Human | 1 | 2016 | 1078 | 0.090 |
Why?
|
Tyrosine | 2 | 2012 | 1427 | 0.080 |
Why?
|
Tosyl Compounds | 2 | 2008 | 115 | 0.080 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2018 | 2423 | 0.080 |
Why?
|
Castration | 1 | 2009 | 149 | 0.080 |
Why?
|
Immediate-Early Proteins | 1 | 2011 | 444 | 0.080 |
Why?
|
Transgenes | 1 | 2012 | 1015 | 0.080 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2013 | 632 | 0.080 |
Why?
|
Coronary Artery Bypass | 1 | 2017 | 2188 | 0.070 |
Why?
|
Male | 20 | 2022 | 363740 | 0.070 |
Why?
|
Anilides | 2 | 2008 | 414 | 0.070 |
Why?
|
Neoplasm Metastasis | 2 | 2018 | 4883 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2016 | 2945 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2016 | 2839 | 0.070 |
Why?
|
Enhancer Elements, Genetic | 1 | 2013 | 1365 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 2018 | 4391 | 0.060 |
Why?
|
Enzyme Activation | 2 | 2013 | 3585 | 0.060 |
Why?
|
Neoplastic Stem Cells | 1 | 2013 | 1352 | 0.060 |
Why?
|
Cell Line | 3 | 2021 | 15540 | 0.060 |
Why?
|
MAP Kinase Kinase 6 | 1 | 2004 | 20 | 0.060 |
Why?
|
Immunohistochemistry | 3 | 2016 | 11033 | 0.060 |
Why?
|
Signal Transduction | 7 | 2018 | 23588 | 0.060 |
Why?
|
Nitriles | 2 | 2008 | 983 | 0.060 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2013 | 1609 | 0.060 |
Why?
|
Transfection | 3 | 2008 | 5742 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3794 | 0.060 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 612 | 0.050 |
Why?
|
Neurons | 1 | 2022 | 9521 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13635 | 0.050 |
Why?
|
Humans | 25 | 2022 | 765823 | 0.050 |
Why?
|
Androgen Receptor Antagonists | 2 | 2017 | 123 | 0.050 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2011 | 2057 | 0.050 |
Why?
|
Cell Survival | 1 | 2011 | 5747 | 0.050 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 693 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2018 | 7846 | 0.050 |
Why?
|
Autocrine Communication | 1 | 2022 | 167 | 0.050 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2022 | 684 | 0.040 |
Why?
|
Transcriptional Activation | 3 | 2017 | 1743 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2021 | 4255 | 0.040 |
Why?
|
Keratin-8 | 1 | 2018 | 11 | 0.040 |
Why?
|
Space Perception | 1 | 2022 | 469 | 0.040 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2021 | 5335 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2011 | 4911 | 0.040 |
Why?
|
Keratin-14 | 1 | 2018 | 57 | 0.040 |
Why?
|
Androgen Antagonists | 3 | 2018 | 1411 | 0.040 |
Why?
|
Ukraine | 1 | 2018 | 151 | 0.040 |
Why?
|
Ligands | 2 | 2021 | 3273 | 0.040 |
Why?
|
Calreticulin | 1 | 2018 | 111 | 0.040 |
Why?
|
Neovascularization, Pathologic | 1 | 2008 | 2629 | 0.040 |
Why?
|
Cytoskeletal Proteins | 1 | 2003 | 1322 | 0.040 |
Why?
|
Chromatin | 2 | 2021 | 2980 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2017 | 6544 | 0.040 |
Why?
|
Receptors, Thrombopoietin | 1 | 2018 | 157 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 3785 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 9 | 1 | 2017 | 68 | 0.030 |
Why?
|
Cell Division | 2 | 2018 | 4471 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2006 | 2878 | 0.030 |
Why?
|
Zebrafish Proteins | 1 | 2003 | 1017 | 0.030 |
Why?
|
Medical Oncology | 1 | 2009 | 2339 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2006 | 2465 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2018 | 544 | 0.030 |
Why?
|
Transplantation, Heterologous | 2 | 2016 | 2391 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2018 | 663 | 0.030 |
Why?
|
Apoptosis | 1 | 2012 | 9512 | 0.030 |
Why?
|
Hospital Bed Capacity | 1 | 2017 | 200 | 0.030 |
Why?
|
RNA Interference | 2 | 2016 | 2827 | 0.030 |
Why?
|
Receptors, Complement 3d | 1 | 2016 | 116 | 0.030 |
Why?
|
Amino Acid Motifs | 1 | 2018 | 924 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 562 | 0.030 |
Why?
|
Length of Stay | 2 | 2020 | 6485 | 0.030 |
Why?
|
Viral Matrix Proteins | 1 | 2016 | 192 | 0.030 |
Why?
|
Tissue Plasminogen Activator | 1 | 2020 | 1166 | 0.030 |
Why?
|
Feedback, Physiological | 1 | 2017 | 479 | 0.030 |
Why?
|
Gene Dosage | 1 | 2018 | 1213 | 0.030 |
Why?
|
Cell Movement | 2 | 2018 | 5190 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2018 | 1166 | 0.030 |
Why?
|
Blood Pressure | 1 | 2009 | 8532 | 0.030 |
Why?
|
Genes, Lethal | 1 | 2013 | 224 | 0.030 |
Why?
|
Cell Respiration | 1 | 2013 | 197 | 0.030 |
Why?
|
Immunoblotting | 1 | 2016 | 1643 | 0.030 |
Why?
|
5-Methylcytosine | 1 | 2013 | 146 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2018 | 2060 | 0.030 |
Why?
|
Models, Biological | 1 | 2009 | 9441 | 0.030 |
Why?
|
Adenine | 1 | 2018 | 994 | 0.030 |
Why?
|
In Situ Hybridization | 1 | 2016 | 1885 | 0.020 |
Why?
|
Cytosine | 1 | 2013 | 212 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1776 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2016 | 871 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2427 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2016 | 1837 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2006 | 12767 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2013 | 446 | 0.020 |
Why?
|
China | 1 | 2017 | 2387 | 0.020 |
Why?
|
Protein Binding | 2 | 2018 | 9297 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2036 | 0.020 |
Why?
|
Antibodies | 1 | 2018 | 2415 | 0.020 |
Why?
|
Phospholipase C delta | 1 | 2009 | 7 | 0.020 |
Why?
|
Fibroblast Growth Factor 5 | 1 | 2009 | 9 | 0.020 |
Why?
|
Piperidines | 1 | 2018 | 1662 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2009 | 12800 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2009 | 16040 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2020 | 3503 | 0.020 |
Why?
|
Cytochrome P-450 CYP1A2 | 1 | 2009 | 68 | 0.020 |
Why?
|
Hippocampus | 1 | 2022 | 3774 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2018 | 2586 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6219 | 0.020 |
Why?
|
Propensity Score | 1 | 2017 | 1967 | 0.020 |
Why?
|
DNA, Viral | 1 | 2016 | 2199 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2016 | 2719 | 0.020 |
Why?
|
Steroid 17-alpha-Hydroxylase | 1 | 2009 | 99 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6765 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1600 | 0.020 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2009 | 166 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1651 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8529 | 0.020 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2009 | 196 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2007 | 9372 | 0.020 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2009 | 276 | 0.020 |
Why?
|
Pyrazoles | 1 | 2018 | 2031 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2013 | 1673 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 1805 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4639 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 22349 | 0.020 |
Why?
|
Female | 5 | 2020 | 396050 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 5786 | 0.020 |
Why?
|
Systole | 1 | 2009 | 935 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 2 | 2013 | 4521 | 0.020 |
Why?
|
Diastole | 1 | 2009 | 785 | 0.020 |
Why?
|
Phosphoserine | 1 | 2006 | 203 | 0.020 |
Why?
|
Pyrimidines | 1 | 2018 | 3047 | 0.020 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2008 | 409 | 0.020 |
Why?
|
Open Reading Frames | 1 | 2009 | 820 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6839 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2013 | 2141 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2008 | 464 | 0.020 |
Why?
|
Odds Ratio | 1 | 2017 | 9653 | 0.010 |
Why?
|
DNA | 1 | 2018 | 7197 | 0.010 |
Why?
|
Mutation | 1 | 2009 | 30188 | 0.010 |
Why?
|
Cyproterone Acetate | 1 | 2003 | 6 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2009 | 15645 | 0.010 |
Why?
|
Purines | 1 | 2006 | 615 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2017 | 5338 | 0.010 |
Why?
|
TCF Transcription Factors | 1 | 2003 | 137 | 0.010 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2003 | 152 | 0.010 |
Why?
|
Adult | 3 | 2018 | 223055 | 0.010 |
Why?
|
India | 1 | 2009 | 2333 | 0.010 |
Why?
|
Europe | 1 | 2009 | 3427 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12821 | 0.010 |
Why?
|
Aged | 3 | 2020 | 171178 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3412 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 59849 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8320 | 0.010 |
Why?
|
Serine | 1 | 2004 | 824 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2009 | 4618 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2016 | 18970 | 0.010 |
Why?
|
Middle Aged | 3 | 2020 | 223016 | 0.010 |
Why?
|
Prevalence | 1 | 2017 | 15832 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2879 | 0.010 |
Why?
|
Histones | 1 | 2009 | 2592 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2009 | 2896 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2016 | 11643 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2004 | 3749 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 24278 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2003 | 6110 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 40109 | 0.010 |
Why?
|
Proteins | 1 | 2009 | 5996 | 0.010 |
Why?
|
Genetic Variation | 1 | 2009 | 6607 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2009 | 9594 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2017 | 65223 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2006 | 5692 | 0.010 |
Why?
|
Risk Factors | 1 | 2017 | 74853 | 0.010 |
Why?
|
Kidney | 1 | 2004 | 7073 | 0.000 |
Why?
|
United States | 1 | 2017 | 72896 | 0.000 |
Why?
|
Adolescent | 1 | 2017 | 88794 | 0.000 |
Why?
|